A new preclinical study from Weill Cornell Medicine found that the protein caspase-5 (CASP5), long thought to be a foot ...
New AACR data highlight stenoparib’s potential in colorectal cancer through WNT pathway modulationThe Stenoparib-DRP® companion ...
A new preclinical study from Weill Cornell Medicine found that the protein caspase-5 (CASP5), long thought to be a foot soldier in the body's defense ...
Iterion Therapeutics announced that two abstracts featuring its first-in-class TBL1 inhibitor, tegavivint, will be presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting.
Researchers are rethinking how we target bowel cancer growth pathways, using patient-derived organoids to identify whether ...
10d
This laser breakthrough supercharges osteoporosis treatment by exposing bone's hidden growth switch
A research team has discovered a new mechanism and drug combination strategy that can effectively treat osteoporosis, a ...
Seoul National University College of Engineering (SNU Engineering) announced that a joint research team led by Prof. Sunghoon ...
Cancer stem cells (CSCs), a critical subpopulation within tumors, drive cancer initiation, progression, metastasis, relapse, ...
Cancer stem cells (CSCs), a critical subpopulation within tumors, drive cancer initiation, progression, metastasis, relapse, ...
Brain organoids reveal that two genetic mutations in DEPDC5 drive epilepsy, disrupting early brain development, and causing ...
Morning Overview on MSN
Researchers find some cancer drugs work differently than their stated targets
As of spring 2026, a cancer drug that has spent years in clinical development as a Wnt/beta-catenin pathway blocker has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results